Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Chemotherapy: A Glimmer of Hope? Reply

被引:0
|
作者
Yang, James Chih-Hsin [1 ]
Puri, Tarun [2 ]
Orlando, Mauro [3 ]
Cheng, Ying [4 ]
机构
[1] Natl Taiwan Univ Hosp, Taipei, Taiwan
[2] Eli Lilly, Gurgaon, Haryana, India
[3] Eli Lilly Interamer, Buenos Aires, DF, Argentina
[4] Jilin Prov Canc Hosp, Changchun, Peoples R China
关键词
CELL LUNG-CANCER; PHASE-III TRIAL; GEFITINIB; ERLOTINIB; THERAPY; PLUS;
D O I
10.1200/JCO.2016.70.6978
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:694 / +
页数:3
相关论文
共 50 条
  • [21] Inhibitors of the epidermal growth factor receptor (EGFR) tyrosine kinase: similarity and differences
    Lokiec, F.
    Douillard, J. -Y.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2011, 67 : S15 - S19
  • [22] Generations of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Perils and Progress
    Emily H. Castellanos
    Leora Horn
    Current Treatment Options in Oncology, 2015, 16
  • [23] Epidermal growth factor receptor tyrosine kinase inhibitors as potential cancer chemopreventives
    Kelloff, GJ
    Fay, JR
    Steele, VE
    Lubet, RA
    Boone, CW
    Crowell, JA
    Sigman, CC
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1996, 5 (08) : 657 - 666
  • [24] Ethnic differences in response to epidermal growth factor receptor tyrosine kinase inhibitors
    Calvo, Emiliano
    Baselga, Jose
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (14) : 2158 - 2163
  • [25] Epidermal growth factor receptor first generation tyrosine-kinase inhibitors
    Martinez-Marti, Alex
    Navarro, Alejandro
    Felip, Enriqueta
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S235 - S246
  • [26] Effects of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors on Immune Checkpoints
    Kamimaki, C.
    Teranishi, S.
    Kobayashi, N.
    Kubo, S.
    Katakura, S.
    Muraoka, T.
    Kanaoka, H.
    Somekawa, K.
    Hirata, M.
    Ikeda, S.
    Hirama, N.
    Ushio, R.
    Manabe, S.
    Yamamoto, M.
    Kudo, M.
    Kaneko, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [27] Small molecule epidermal growth factor receptor tyrosine kinase inhibitors: An overview
    Normanno, N
    Maiello, MR
    Mancino, M
    De Luca, A
    JOURNAL OF CHEMOTHERAPY, 2004, 16 : 36 - 40
  • [28] Generations of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Perils and Progress
    Castellanos, Emily H.
    Horn, Leora
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2015, 16 (10)
  • [29] Management of diarrhea induced by epidermal growth factor receptor tyrosine kinase inhibitors
    Hirsh, V.
    Blais, N.
    Burkes, R.
    Verma, S.
    Croitoru, K.
    CURRENT ONCOLOGY, 2014, 21 (06) : 329 - 336
  • [30] Small-molecule epidermal growth factor receptor tyrosine kinase inhibitors
    Janmaat, ML
    Giaccone, G
    ONCOLOGIST, 2003, 8 (06): : 576 - 586